Metametrix Clinical Laboratory
FAQ | Ordering Info | Site Map | Contact us


Print
AA/EPA Ratio - Plasma
Fatty Acid Logo

AA/EPA Ratio

This unique test measures the ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA) in plasma. This ratio of the principle omega-3 and omega-6 fatty acids is a measure of the body’s eicosanoid balance. Balancing the eicosanoids in the body is an excellent way for managing heart disease and other chronic and inflammatory processes.

Recently, a great deal of interest has been paid to the ratio of the fatty acids arachidonic acid (AA) to eicosapentaenoic acid (EPA). According to Dr. Sears, a lower AA/EPA ratio indicates a better balance of "good" and "bad" eicosanoids in your body. An AA/EPA ratio of 1.5 is considered to be ideal, since this is the ratio found in the Japanese population having the greatest longevity and the lowest incidence of cardiovascular disease. The average AA/EPA of Americans is approximately 11, and for patients with inflammatory conditions and neurological disorders, the AA/EPA ratio will be in excess of 20.

 

 

 

older man

Metametrix AA/EPA Ratio features:

  • True quantitative analysis of fatty acids
  • A choice of specimens: from plasma, and available soon, from a finger stick
  • Metametrix quality and reliability backed by over 20 years of experience.
Clinician Info
Test name: 0240 - AA/EPA Ratio
Description: This unique test measures the ratio of Arachidonic Acid (AA) to Eicosapentaenoic Acid (EPA) in plasma or serum. This ratio of the principle omega-3 and omega-6 fatty acids is a measure of the body’s eicosanoid balance. Balancing the eicosanoids in the body is an excellent way for managing heart disease and other chronic and inflammatory processes.
Method: GC/MS
Turnaround time: 12-14 days, 10 days average
Analytes: Eicosapentaenoic Acid (EPA)
Arachidonic Acid (AA)
AA/EPA Ratio
CPT codes:

82726 - Fatty acids x2
The PDF should now automatically load in another browser window.

If the PDF has not yet loaded, please click link below:



If you do not have the free Adobe Acrobat Reader, download it here.
 
references aaepa
 

Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression.
Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Lipids. 1996 Mar;31 Suppl:S157-61.

Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments
and biomarkers of bone formation in rats.

Watkins BA, Li Y, Allen KG, Hoffmann WE, Seifert MF. J Nutr. 2000 Sep;130(9):2274-84.

Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio
Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE.
Pharmacotherapy. 2007 May;27(5):633-8. Pharmacotherapy. 2007 May;27(5):633-8.

Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases.
Simopoulos AP. Biomed Pharmacother. 2006 Nov;60(9):502-7. Epub 2006 Aug 28. 

Imbalances in Dietary Consumption of Fatty Acids, Vegetables, and Fruits Are Associated With Risk for Crohn's Disease in Children.
Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, Israel D, Mack D, Ghadirian P, Deslandres
C, Chotard V, Budai B, Law L, Levy E, Seidman EG. Am J Gastroenterol. 2007 Jul. 7

Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons.
Lauretani F, Bandinelli S, Benedetta B, Cherubini A, Iorio AD, Blè A, Giacomini V, Corsi AM, Guralnik JM, Ferrucci L.
Eur J Neurol. 2007 Jul;14(7):801-8.

Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events.
Harris WS, Poston WC, Haddock CK. Atherosclerosis. 2007 Jul;193(1):1-10. Epub 2007 May 15.

Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults.
Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, Lemeshow S, Glaser R. Psychosom Med. 2007 Apr;69(3):217-24. Epub 2007 Mar 30.

Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.
Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM. J Clin Endocrinol Metab. 2006 Feb;91(2):439-46. Epub 2005 Oct 18.

Omega-3 fatty acids upregulate adult neurogenesis
Beltz BS, Tlusty MF, Benton JL, Sandeman DC. Neurosci Lett. 2007 Mar 26;415(2):154-8. Epub 2007 Jan 7.